Provectus Biopharmaceuticals, Inc. (PVCT)

USD 0.13

(-0.76%)

Annual Balance Sheets

(In USD)
Breakdown 2023 2022 2021 2020 2019 2018
Total Assets 1.44 Million 2.03 Million 3.51 Million 589.2 Thousand 1.47 Million 1.98 Million
Total Current Assets 1.36 Million 1.89 Million 3.44 Million 423.67 Thousand 996.01 Thousand 1.01 Million
Cash And Short Term Investments 1.02 Million 21.6 Thousand 682.98 Thousand 97.23 Thousand 590.7 Thousand 50.98 Thousand
Cash and Cash Equivalents 1.02 Million 21.6 Thousand 682.98 Thousand 97.23 Thousand 590.7 Thousand 50.98 Thousand
Short Term Investments - - - - - -
Net Receivables 476.00 394.00 5107.00 3930.00 55.05 Thousand 595.32 Thousand
Inventory - 1.41 Million 2.42 Million - - -
Other Current Assets 337.52 Thousand 467.08 Thousand 329.9 Thousand 322.51 Thousand 350.24 Thousand 370.2 Thousand
Total Non-Current Assets 84.04 Thousand 138.06 Thousand 71.39 Thousand 165.52 Thousand 480.89 Thousand 971.7 Thousand
Net PPE 84.04 Thousand 138.06 Thousand 71.39 Thousand 165.52 Thousand 252.78 Thousand 72.47 Thousand
Good Will And Intangible Assets - - - - 228.1 Thousand 899.22 Thousand
Good Will - - - - - -
Intangible Assets - - - - 228.1 Thousand 899.22 Thousand
Long-Term Investments - - - - - -
Tax Assets - - - - - -
Other Non Current Assets - -138.06 Thousand -71.39 Thousand -165.52 Thousand -480.89 Thousand -
Other Assets - - - - - -
Total Liabilities 9.04 Million 8.26 Million 7.7 Million 30.79 Million 25.54 Million 19.4 Million
Total Current Liabilities 9.01 Million 8.19 Million 7.7 Million 30.71 Million 3.02 Million 4.1 Million
Account Payables 1.67 Million 2.09 Million 1.28 Million 956.86 Thousand 1.12 Million 3.31 Million
Tax Payables - - - - - -
Short Term Debt 3 Million 2.11 Million 1.74 Million 23.71 Million 576.42 Thousand -
Deferred Revenue 953.24 Thousand 1.51 Million 2.5 Million - - -
Other Current Liabilities 3.38 Million 2.47 Million 2.16 Million 6.04 Million 1.32 Million 790.35 Thousand
Total Non Current Liabilities 25.29 Thousand 73.37 Thousand - 83.84 Thousand 22.52 Million 15.3 Million
Long-Term Debt 25.29 Thousand 73.37 Thousand - 83.84 Thousand 19.79 Million 13.93 Million
Deferred Revenue Non Current - - - - - -
Deferred Tax Liabilities Non Current - - - - - -
Other Non Current Liabilities - - - - 2.72 Million 1.37 Million
Other Liabilities - - - - - -
Total Equity -7.59 Million -6.22 Million -4.18 Million -30.2 Million -24.07 Million -17.41 Million
Stock Holders Equity -7.59 Million -6.22 Million -4.18 Million -30.2 Million -24.07 Million -17.41 Million
Common Stock 419.52 Thousand 419.49 Thousand 419.44 Thousand 398.8 Thousand 389.88 Thousand 384.61 Thousand
Retained Earnings -252.69 Million -249.58 Million -246.03 Million -240.49 Million -233.81 Million -226.89 Million
Accumulated other comprehensive income -60.16 Thousand -35.67 Thousand -34.46 Thousand -34.09 Thousand -24 Thousand -
Common Stock Equity -7.59 Million -6.22 Million -4.18 Million -30.2 Million -24.07 Million -17.41 Million
Capital Lease Obligation 25.29 Thousand 117.79 Thousand 45.61 Thousand 129.16 Thousand 207.08 Thousand -
Total Investments - - - - - -
Total Debt 3.02 Million 2.18 Million 1.74 Million 23.79 Million 20.37 Million 13.93 Million
Net Debt 1.99 Million 2.16 Million 1.06 Million 23.69 Million 19.78 Million 13.88 Million

Balance Sheet Charts